Tag: begin
Facebook owner Meta sees latest layoffs begin
Americans Begin Returning to Cities After Remote-Work Exodus, Data Shows
The exodus of people fleeing large urban areas during the height of the pandemic appears to be reversing, according to data from the Census Bureau released Thursday. Many workers who could telecommute abandoned crowded cities and counties for suburban or rural areas when covid struck, causing demographers and businesses to wonder whether the movement signified a permanent shift. But the overall patterns of population change are moving toward pre-pandemic rates, the bureau’s Vintage 2022 estimates of population and components of change show.
Eleven of the 15 largest metro areas gained residents or lost fewer people compared with the previous year, including the D.C. metro area, New York City, the San Francisco Bay Area, and Seattle, according to an analysis by Brookings Institution senior demographer William Frey…. Among the most striking recorded shifts were in Manhattan and San Francisco, both of which lost population at a significant rate between 2020 and 2021. Manhattan, which shrank by 5.87 percent in 2021, grew by 1.11 percent last year. San Francisco lost 6.79 percent of its population in 2021 but shrank by only a third of a percentage point last year. Both are home to a large number of people who were able to work remotely during the pandemic. Covid rates in New York City were especially high early in the pandemic, and many Manhattan residents moved to outlying counties….
“Many counties with large universities saw their populations fully rebound this year as students returned,” said Christine Hartley, assistant division chief for estimates and projections in the Census Bureau’s population division.
The article also makes the point that immigration into America was temporarily restricted during the pandemic, so outflows never had a chance to be counterbalanced by inflows. And the exodus to the suburbs may have already peaked. Last year Manhattan gained 17,472 people, the article points out, while counties outside the city lost residents. The Census Bureau notes that was a pattern for 2022: “the smallest counties nationally, those with populations below 10,000, experienced more population loss (60.8%) than gains (38.3%); while the largest counties, having populations at or greater than 100,000, largely experienced population increases (68%).”
Beyond that, the executive director of the DC Fiscal Policy Institute argues that it’s just too soon to know whether the pandemic-era outflow from cities was permanent. “We’ve just been through a major health and economic shock. There’s been what I call a doomsday narrative about what’s going to happen, with predictions of empty downtowns and city centers that wither and die.” They believe the new census data “should give us pause in terms of declaring that we’ve arrived at a new normal. It’s highly likely that some of the folks who left will come back, and we really don’t know if it’s going to be a lot of them or just a small portion.”
Read more of this story at Slashdot.
Let the AI Coding Wars Begin!
Begin Your Shadow Over Morrowind Adventure with The Elder Scrolls Online: Scribes of Fate Dungeon DLC
Apple to Begin Selling AirTag Competitor Chipolo’s CARD Spot for Wallets
Priced at $35, the Chipolo CARD Spot is a card-shaped item tracker designed for use with wallets. The accessory allows you to easily track the location of a wallet in the Items tab of the Find My app on the iPhone, iPad, and Mac. Apple does not offer a card-shaped version of the AirTag, giving the CARD Spot a unique advantage for wallets. For additional information, read our hands-on review of the CARD Spot published last year.
Apple launched the AirTag in April 2021, and the hardware has not been updated since. Apple did refresh its AirTag accessories lineup last week.
This article, “Apple to Begin Selling AirTag Competitor Chipolo’s CARD Spot for Wallets” first appeared on MacRumors.com
Discuss this article in our forums
ChatGPT’s API Is Here. Let the AI Gold Rush Begin
FDA reportedly denied Neuralink’s request to begin human trials of its brain implant
Despite the repeated and audacious claims by its sometimes CEO, Elon Musk, the prospects of brain-computer interface (BCI) startup Neuralink bringing a product to market remain distant, according to a new report from Reuters. The BCI company was apparently denied authorization by the FDA in 2022 to conduct human trials using the same devices that killed all those pigs — namely on account of; pig killing.
“The agency’s major safety concerns involved the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue,” current and former Neuralink employees told Reuters.
The FDA’s concerns regarding the battery system and its novel transdermal charging capabilities revolve around the the device’s chances of failure. According to Reuters, the agency is seeking reassurances that the battery is “very unlikely to fail” because should it do so, the discharge of electrical current or heat energy from a ruptured pack could fry the surrounding tissue.
The FDA is also very concerned with potential problems should the device need to be removed wholesale, either for replacement or upgrades, due to the minuscule size of the electrical leads that extend into the patient’s grey matter. Those leads are so small and delicate that they are at risk of breaking off during removal (or even during regular use) and then migrating to other parts of the brain where they might get lodged in something important.
During Neuralink’s open house last November, Musk’s confidently claimed the company would secure FDA approval “within six months,” basically by this spring. That estimate is turning out to be as accurate as his guesses for when the Cybertruck might finally enter production. “He can’t appreciate that this is not a car,” one employee told Reuters. “This is a person’s brain. This is not a toy.” Neuralink did not respond to requests for comment.
This article originally appeared on Engadget at https://www.engadget.com/fda-reportedly-denied-neuralinks-request-to-begin-human-trials-of-its-brain-implant-204454485.html?src=rss